1-20 of 83
Bart J. Biemond
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Assessment of Neurocognitive Functioning in Sickle Cell Disease and Thalassemia and the Association with Silent Cerebral Infarcts and Cerebral Hemodynamics and Oxygen Metabolism

Liza Afzali-Hashemi, Melanie Franse, Koen P.A. Baas, Anouk Schrantee, John C. Wood, Aart J Nederveen, Bart J. Biemond, Sharon O'Neil
Journal: Blood
Blood (2023) 142 (Supplement 1): 1153.
https://doi.org/10.1182/blood-2023-189194
Published: 2023
Journal Articles

Plasma Proteome Profiling of Sickle Cell Patients Reveals Activation of Inflammatory Pathways during Steady State and Vaso-Occlusive Crisis

Lydian A. de Ligt, Aafke E. Gaartman, Kadère Konté, Taco W. Kuijpers, Karin Fijnvandraat, Bart J. Biemond, Robin van Bruggen, Erfan Nur
Journal: Blood
Blood (2023) 142 (Supplement 1): 1108.
https://doi.org/10.1182/blood-2023-179239
Published: 2023
Journal Articles

Over 4 Years of Safety and Efficacy with Voxelotor Treatment for Patients with Sickle Cell Disease: Updated Results from an Open-Label Extension of the Phase 3 HOPE Trial

Maureen Okam Achebe, Hoda MA Hassab, Salam Al-Kindi, Clark Brown, Paul Telfer, Bart J. Biemond, Thokozeni Lipato, Mark Davis, Sarah Gray, Victor R. Gordeuk
Journal: Blood
Blood (2023) 142 (Supplement 1): 2527.
https://doi.org/10.1182/blood-2023-188616
Published: 2023
Journal Articles

Analysis of Volatile Organic Compounds in Exhaled Air in Patients with Sickle Cell Disease during Vaso-Occlusive Episodes

Caroline Vuong, Paul Brinkman, Harriët Heijboer, Erfan Nur, Cornelia De Groot - Eckhardt, Suzanne W.J. Terheggen-Lagro, Bart J. Biemond, Anke-Hilse Maitland-van der Zee, Karin Fijnvandraat
Journal: Blood
Blood (2023) 142 (Supplement 1): 1131.
https://doi.org/10.1182/blood-2023-180835
Published: 2023
Journal Articles

Pyruvate Kinase Thermostability Is Associated with Red Blood Cell Adhesion, Deformability and Oxygen Affinity in Patients with Sickle Cell Disease

Marissa J.M. Traets, Sigrid van der Veen, Jennifer Bos, Laura van Pelt, Aida Kidane, Brigitte A. van Oirschot, Wouter W. van Solinge, Saskia Schols, Mandy N. Lauw, Marjon H. Cnossen, Erfan Nur, Bart J. Biemond, Eduard J. Van Beers, Anita W. Rijneveld, Richard van Wijk, Minke A.E. Rab
Journal: Blood
Blood (2023) 142 (Supplement 1): 561.
https://doi.org/10.1182/blood-2023-180755
Published: 2023
Journal Articles

One-Year Safety and Efficacy of Mitapivat in Sickle Cell Disease: Follow-up Results of a Phase 2, Open-Label Study

Myrthe J. van Dijk, Minke A.E. Rab, Brigitte A. van Oirschot, Jennifer Bos, Cleo Derichs, Anita W. Rijneveld, Marjon H. Cnossen, Erfan Nur, Bart J. Biemond, Marije Bartels, Judith J.M. Jans, Wouter W. van Solinge, Roger E.G. Schutgens, Richard van Wijk, Eduard J. Van Beers
Journal: Blood
Blood (2023) 142 (Supplement 1): 2515.
https://doi.org/10.1182/blood-2023-172829
Published: 2023
Journal Articles

The Effect of Voxelotor on Erythrocyte Deformability, Neutrophil Phenotype and Endothelial Activation

Kadère Konté, Aafke E. Gaartman, Isha Tanwar, Boukje Beuger, Martijn Veldthuis, Rob Van Zwieten, Robin van Bruggen, Bart J. Biemond, Erfan Nur
Journal: Blood
Blood (2023) 142 (Supplement 1): 3872.
https://doi.org/10.1182/blood-2023-185822
Published: 2023
Journal Articles

The Effect of Allogeneic Hematopoietic Stem Cell Transplantation on Sickle Cell Disease-Related Organ Damage: A Systematic Review and Meta-Analysis

Elisabeth Dovern, Mesire Aydin, Komeil Alizade, Bart J. Biemond, Erfan Nur
Journal: Blood
Blood (2023) 142 (Supplement 1): 2364.
https://doi.org/10.1182/blood-2023-174436
Published: 2023
Journal Articles

A Novel Prognostic Model for Patients with Acute Myeloid Leukemia in First Relapse with Improved Prognostic Accuracy

Niek G. Van Der Maas, Dimitri Breems, Clara Klerk, Thomas Pabst, Patrycja Gradowska, Bart J. Biemond, Jurgen Kuball, Janine Van Elssen, Otto Visser, Marie-Christiane Vekemans, Carlos Graux, Johan Maertens, H. Berna Beverloo, Peter J. M. Valk, Gert J. Ossenkoppele, Bob Lowenberg, Geert A. Huls, Jan J. Cornelissen, Jurjen Versluis
Journal: Blood
Blood (2023) 142 (Supplement 1): 724.
https://doi.org/10.1182/blood-2023-180812
Published: 2023
Journal Articles

Comparison of Hidac Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Study

Man Wai Tang, Deborah van der Tuin, Mesire Aydin, Jarom Heijmans, Arjan A. van de Loosdrecht, Ellen Meijer, Caroline E. Rutten, Marielle Wondergem, Jeroen J.W.M. Janssen, Marjolein Donker, Mette D. Hazenberg, Sonja Zweegman, Bart J. Biemond, David C. de Leeuw, Erfan Nur
Journal: Blood
Blood (2022) 140 (Supplement 1): 3287–3289.
https://doi.org/10.1182/blood-2022-163042
Published: 2022
Journal Articles

The HOVON 100 Study in Adult Acute Lymphoblastic Leukemia Re-Analysed By Multi-State Modeling: Benefits and Risks of Clofarabine

Sjoerd J.F. Hermans, Yvette Norden, Jurjen Versluis, Anita W. Rijneveld, Okke De Weerdt, Bart J. Biemond, Arjan A. van de Loosdrecht, Lotte E. Van der Wagen, Mar Bellido, Michel Van Gelder, Walter J.F.M. Van der Velden, Dominik Selleslag, Danielle van Lammeren, Vincent H.J. van der Velden, Liesbeth C. de Wreede, Douwe Postmus, Francesco Pignatti, Jan J. Cornelissen
Journal: Blood
Blood (2022) 140 (Supplement 1): 8890–8892.
https://doi.org/10.1182/blood-2022-163055
Published: 2022
Journal Articles

Cerebral Oxygen Metabolism in Patients with Mild and Severe Sickle Cell Disease and Thalassemia

Liza Afzali-Hashemi, Koen P.A. Baas, Anouk Schrantee, Erfan Nur, John C Wood, Aart J. Nederveen, Bart J. Biemond
Journal: Blood
Blood (2022) 140 (Supplement 1): 8258–8259.
https://doi.org/10.1182/blood-2022-168736
Published: 2022
Journal Articles

Protocol Adherence for Adult Sickle Cell Patients Presenting with Vaso-Occlusive Crises on a Tertiary Teaching Hospital Emergency Department

Charlotte F.J. Van Tuijn, Mitchel E. van Straaten, Erfan Nur, Bart J. Biemond, Jarom Heijmans
Journal: Blood
Blood (2022) 140 (Supplement 1): 11135–11136.
https://doi.org/10.1182/blood-2022-166551
Published: 2022
Journal Articles

Improved T-Cell Chimerism and Successful Withdrawal of Immunosuppression after Non-Myeloablative Stem Cell Transplantation for Sickle Cell Disease with Azathioprine/Hydroxyurea Preconditioning Added to Alemtuzumab/TBI Conditioning

Elisabeth Dovern, Mesire Aydin, Man Wai Tang, Liesbeth E.M. Suijk, Gerianne M. Hoogendoorn, Charlotte F.J. Van Tuijn, Jean-Louis Kerkhoffs, Caroline E. Rutten, Sacha S. Zeerleder, Mette D. Hazenberg, Bart J. Biemond, Erfan Nur
Journal: Blood
Blood (2022) 140 (Supplement 1): 10476–10477.
https://doi.org/10.1182/blood-2022-159390
Published: 2022
Journal Articles

Pleiotropic Effects of Hydroxyurea on Red Blood Cell and Neutrophil Phenotype in Patients with Sickle Cell Disease; Data from the Notice Study

Aafke E. Gaartman, Lydian A. de Ligt, Anton T.J. Tool, Boukje M. Beuger, Martijn Veldthuis, Taco W. Kuijpers, Rob van Zwieten, Bart J. Biemond, Robin Van Bruggen, Erfan Nur
Journal: Blood
Blood (2022) 140 (Supplement 1): 2551–2553.
https://doi.org/10.1182/blood-2022-169070
Published: 2022
Journal Articles

Quality of Life and Personal Life Goals of Adult Sickle Cell Disease Patients after Curative Allogeneic Stem Cell Transplantation: A Mixed Methods Study

Elisabeth Dovern, Sterre J.A.M. Nijland, Maud M. Van Muilekom, Liesbeth E.M. Suijk, Hilda Mekelenkamp, Bart J. Biemond, Lotte Haverman, Erfan Nur
Journal: Blood
Blood (2022) 140 (Supplement 1): 1393–1394.
https://doi.org/10.1182/blood-2022-159406
Published: 2022
Journal Articles

Untargeted Metabolomics on Dried Blood Spots of Patients with Sickle Cell Disease Treated with the Pyruvate Kinase Activator Mitapivat

Myrthe J. van Dijk, Sigrid van der Veen, Minke A.E. Rab, Brigitte A. van Oirschot, Jennifer Bos, Cleo Derichs, Anita W. Rijneveld, Marjon H. Cnossen, Erfan Nur, Bart J. Biemond, Marije Bartels, Judith J.M. Jans, Richard van Wijk, Eduard J. van Beers
Journal: Blood
Blood (2022) 140 (Supplement 1): 21–23.
https://doi.org/10.1182/blood-2022-155997
Published: 2022
Journal Articles

Increased LFS Following Hematopoietic Cell Transplantation As Compared to Conventional Consolidation Therapy in Patients >60 Years with AML in First Complete Remission and a Matched Donor: Results of a Randomized Phase III Study

Dietger Niederwieser, Dirk Hasenclever, Wolfgang E. Berdel, Bart J. Biemond, Haifa Kathrin Al-Ali, Yves Chalandon, Michel Van Gelder, Christian Junghanss, Goesta Gahrton, Mathias Haenel, Rüdiger Hehlmann, Thomas Heinicke, Andreas Hochhaus, Simona Iacobelli, Rien van Marwijk Kooy, Nicolaus Kröger, Jeroen J.W.M. Janssen, Madlen Jentzsch, Frank Breywisch, Mohamad Mohty, Stavroula Masouridi-Levrat, Gert Ossenkoppele, Jakob Passweg, Wolfram Pönisch, Johannes Schetelig, Christoph Schliemann, Sebastian Schwind, Matthias Stelljes, Peter JM Valk, Bob Lowenberg, Jan J. Cornelissen
Journal: Blood
Blood (2022) 140 (Supplement 1): 2126–2129.
https://doi.org/10.1182/blood-2022-157684
Published: 2022
Journal Articles

The Effect of Hematopoietic Stem Cell Transplantation on Cerebral Perfusion and Oxygen Metabolism in Patients with Sickle Cell Disease

Liza Afzali-Hashemi, Koen P.A. Baas, Elisabeth Dovern, Anouk Schrantee, Aart J. Nederveen, Erfan Nur, Bart J. Biemond
Journal: Blood
Blood (2022) 140 (Supplement 1): 1634–1635.
https://doi.org/10.1182/blood-2022-169234
Published: 2022
Journal Articles

Voxelotor Treatment Leads to Improved Viability of Sickle Erythrocytes and Altered Neutrophil Phenotype

Kadère Konté, Aafke E. Gaartman, Boukje M. Beuger, Martijn Veldthuis, Rob van Zwieten, Robin Van Bruggen, Bart J. Biemond, Erfan Nur
Journal: Blood
Blood (2022) 140 (Supplement 1): 11114–11115.
https://doi.org/10.1182/blood-2022-170527
Published: 2022